This large cap fund is staying above water in this bear market by being the ‘antithesis of ARK’

James Abate expects that his fund distinguished itself this year by maintaining a traditional bottom-up perspective on stocks. Source link

Read more

Passage of Inflation Reduction Act gives Medicare historic new powers over drug prices

The legislation represents a historic expansion of Medicare's power that was fiercely opposed by the pharmaceutical industry. Source link

Read more

Stocks head into August with a tailwind, as investors await jobs data and a slew of earnings

Dozens of companies report earnings next week, but it may be big economic data, like Friday's jobs report, that takes

Read more

Three stock market themes to play in the third quarter

Analysts gave us three ideas that could generate some gains and income in the third quarter, and a top pick

Read more

Signs point to biotech M&A heating up, Wells Fargo says. Here’s where to look

"Big BioPharma needs growth," says Wells Fargo analyst Mohit Bansal in a research note that anticipates a pick-up in smaller

Read more

Investors bet on obesity drugs before without much success. Why this next wave could be different

New obesity treatments are helping patients lose 15% or more of their body weight, and changing attitudes could expand access

Read more